Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03471221 · ClinicalTrials.gov registry record · NA
Helping Improve Pediatric Patient Outcomes
A NA study, sponsored by Kaiser Permanente.
- Completed
- Registry status
- NA
- Development phase
- 26
- Enrollment target
NCT03471221 is a NA study that has completed, run by Kaiser Permanente. The registered enrollment target is 26 participants.
The verdict
NCT03471221, a NA study, has completed, sponsored by Kaiser Permanente.
- COMPLETED
- Registry status
- NA
- Development phase
- 26 participants
- Enrollment target
Study Summary
This study involves two distinct activities: The first is a randomized controlled trial (RCT) to assess the efficacy and safety of therapy dog visits for children with cancer. This activity has the following specific objectives: 1. To assess the effect of therapy dog visits on psychosocial outcomes and satisfaction with care among pediatric oncology inpatients. 2. To determine whether therapy dog visits increase microbial levels on children's hands. The Investigators hypothesize that therapy dog visits will reduce patient distress, lower treatment-related anxiety, increase happiness, and improve satisfaction with hospital care. The Investigators further hypothesize that therapy dog visits (including standard hand sanitization) will not increase microbial levels on children's hands. Once the main study aims for the first study activity have been completed, the research study team will begin recruitment for the second activity. The second activity is an observational study to describe microbial levels before a dog visit, after a dog visit but before hand cleaning, and after hand cleaning. This phase will provide additional information for Aim 2 that cannot be obtained during the RCT given the nature of the RCT design. The Investigators will proceed with the observational study only if all main study activities can be completed within the study timeline.
Interventions
- BEHAVIORAL Therapy Dog Visit
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2018-03-19 |
| Est. Completion | 2020-04-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03471221
The ClinicalTrials.gov registry entry for NCT03471221 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 26 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Kaiser Permanente, which has 294 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Therapy Dog Visit is the first listed.
NCT03471221 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03471221 about?
NCT03471221 is a clinical study titled "Helping Improve Pediatric Patient Outcomes". This study involves two distinct activities: The first is a randomized controlled trial (RCT) to assess the efficacy and safety of therapy dog visits for children with cancer. This activity has the following specific objectives: 1. To assess the effect of therapy dog visits on psychosocial outcome...
What is the current status of trial NCT03471221?
This trial is currently completed. It is a NA study. The enrollment target is 26 participants. The study started on 2018-03-19. Estimated completion is 2020-04-30.
What interventions are being tested in trial NCT03471221?
The interventions under investigation include: Therapy Dog Visit (BEHAVIORAL).
Who is sponsoring clinical trial NCT03471221?
This trial is sponsored by Kaiser Permanente, which has 294 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.